The Chinese Parkinson's Disease With LRRK2 Variants Registry
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive LRRK2 variants
Locations
Other Locations
China
Xiangya Hospital of Central South University
RECRUITING
Changsha
Contact Information
Primary
Jifeng Guo, Ph.D.
guojifeng2003@163.com
+8613974936815
Backup
Beisha Tang, Ph.D.
bstang7398@163.com
+8613974856709
Time Frame
Start Date: 2017-02-01
Estimated Completion Date: 2027-02-01
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Xiangya Hospital of Central South University